Newsroom
Sorted by: Latest
-
ARDT BREAKING CLASS ACTION NEWS: BFA Law has Sued Ardent Health, Inc. for Securities Fraud after Collectability Issues lead to 33% Stock Drop -- Investors Notified to Contact the Firm
NEW YORK--(BUSINESS WIRE)--BFA Law has Sued Ardent Health, Inc. for Securities Fraud after Collectability Issues lead to 33% Stock Drop -- Investors Notified to Contact the Firm...
-
Konik Heavy Duty Products Introduces Galvanized, Quick-Install Mud Flap Bracket for Commercial Trucks and Van Trailers
LAFAYETTE, Ind.--(BUSINESS WIRE)--Konik Heavy Duty Products today announced the release of its Quick-Install Mud Flap Bracket, a galvanized, field-service solution designed to help fleets restore roadworthiness and DOT compliance quickly—without welding, drilling, or special tools. Designed for operators, fleets, dealers, and maintenance teams, the bracket mounts directly to I‑beam crossmembers using a formed, clamp-style design. Spring tabs and a simple bolt-clamp system apply constant pressur...
-
i3 Broadband Named a 2025 Nextdoor Neighborhood Fave!
EAST PEORIA, Ill.--(BUSINESS WIRE)--i3 Broadband, Midwest-based fiber-optic internet provider, announced today it has been named a 2025 Nextdoor Neighborhood Fave! These annual awards by Nextdoor recognizes local businesses and service providers that neighbors “love” most, based on the number of recommendations and “Faves” received on the Nextdoor platform throughout the year. By winning the award, I3 Broadband will receive greater visibility on the Nextdoor app, a Neighborhood Fave badge on it...
-
Stensul Named a 2026 “Best Place To Work” by Built In
NEW YORK--(BUSINESS WIRE)--Stensul, the Campaign Creation Platform for enterprise marketing teams, today announced it has been recognized by Built In as one of the Best Places to Work in 2026. The annual awards honor employers across the U.S. whose benefits and compensation set the standard for today’s workforce. Stensul was selected as one of the best midsize companies to work for in New York City, scoring among the top 100 companies for 2026. “This recognition reinforces something we believe...
-
Tanzania Glucose Syrup Market Report 2025 | Emerging Trends, Shares, Investment Opportunities and Competitive Intelligence to 2031 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Tanzania Glucose Syrup Market | Emerging Trends, Shares, Investment Opportunities and Competitive Intelligence" has been added to ResearchAndMarkets.com's offering. Projected to grow at a CAGR of 11.2% from 2025 to 2031, Tanzania's glucose syrup market is poised for expansion, primarily driven by the manufacturing and agro-processing sectors. The Tanzania Agricultural Development Bank's substantial loan disbursements to agro-processing units highlight the focus on...
-
Radial Equity Partners Announces Acquisition of Cortina
FRANKLIN PARK, Ill.--(BUSINESS WIRE)--Radial Equity Partners Announces Acquisition of Cortina...
-
agilon health, inc. (AGL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AGILON HEALTH, INC. (AGL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email...
-
Resumen: Daiichi Sankyo y GENESIS Pharma firman un acuerdo exclusivo para la comercialización de VANFLYTA ® en Europa Central y Oriental
MÚNICH--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) y GENESIS Pharma han firmado un acuerdo exclusivo de licencia y suministro para la distribución y comercialización de VANFLYTA® (quizartinib) en 13 mercados de Europa Central y Oriental para el tratamiento de pacientes adultos con leucemia mieloide aguda (LMA) FLT3-ITD positiva recién diagnosticada. Según los términos del acuerdo, Daiichi Sankyo se encargará de la fabricación y el suministro de VANFLYTA, mientras que GENESIS Pharma dirigirá la...
-
Daiichi Sankyo und GENESIS Pharma schließen Exklusivvertrag über die Vermarktung von VANFLYTA® in Mittel- und Osteuropa
MÜNCHEN--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) und GENESIS Pharma haben eine exklusive Lizenz- und Liefervereinbarung für den Vertrieb und die Vermarktung von VANFLYTA® (Quizartinib) in 13 Märkten in Mittel- und Osteuropa zur Behandlung von erwachsenen Patienten mit neu diagnostizierter FLT3-ITD-positiver akuter myeloischer Leukämie (AML) geschlossen. Gemäß den Vertragsbedingungen ist Daiichi Sankyo für die Herstellung und Lieferung von VANFLYTA verantwortlich, während GENESIS Pharma die...
-
Oshkosh Corporation Wins 2026 CES Picks Award from TWICE for its Collision Avoidance Mitigation System (CAMS)
LAS VEGAS--(BUSINESS WIRE)--Today at CES, Oshkosh Corporation (NYSE: OSK), a leading innovator of purpose-built vehicles, equipment and services, announced it was selected as a winner in this year’s CES Picks Awards. Oshkosh Corporation was recognized within the TWICE category for its Collision Avoidance Mitigation System (CAMS). The Picks Awards recognize and celebrate brands at the forefront of innovation, honoring standout products and creative solutions. Judged by industry experts, the awar...